New Non-Invasive devices aim to spot hidden blood vessel damage

NCT ID NCT07604922

Not yet recruiting Knowledge-focused Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This study will test two new non-invasive devices (HEMI and SPG-NINOX) that measure small blood vessel function in 165 adults. Participants include healthy volunteers and people with high blood pressure, type 2 diabetes, or chronic kidney disease. The goal is to see if these devices can detect early blood vessel changes linked to these conditions, without any needles or procedures.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could lead to a simple, non-invasive way to detect early blood vessel damage in people with kidney disease, diabetes, or high blood pressure.
What could go wrong: This is an early observational study, not a treatment trial. The devices are still investigational, and results may not lead to a widely available test.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome hypertensive disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASE HYPERTENSION (HTN) TYPE 2 DIABETES MELLITUS (T2DM)

Contacts and locations

Locations

INSERM U970, Equipe 7, 56 rue Leblanc

Paris, 75015, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.